L. V. Manzyuk

Publications

460

Citations

H-Index

2022

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Centre Oscar Lambret

L. V. Manzyuk is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in radiation oncology, oncology, and gynecology oncology.

Top concepts

MedicineOncologyPathologyGynecologyCancer TherapyVulvar DiseasesRadiation OncologyGynecology Oncology

Publications per year

2022–2022

Publications

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

Michele Maio, Paolo A. Ascierto, L. V. Manzyuk et al. · Annals of Oncology · 2022 · 404 citations · Full text

Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study

Ronnie Shapira‐Frommer, Linda Mileshkin, L. V. Manzyuk et al. · Gynecologic Oncology · 2022 · 56 citations

Vulvar Diseases, Medicine, Keynote-158 Study +8

Rows per page

1–2 of 2